ImmuCell Corporation Current Federal Tax Expense (Benefit)
ImmuCell Corporation (ICCC) reported Current Federal Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentFederalTaxExpenseBenefit · last filed 2026-03-30
- ImmuCell Corporation current federal tax expense (benefit) for fiscal 2025 was $0.00.
- ImmuCell Corporation current federal tax expense (benefit) for fiscal 2024 was $0.00.
- ImmuCell Corporation current federal tax expense (benefit) for fiscal 2015 was $641.73K.
- ImmuCell Corporation current federal tax expense (benefit) for fiscal 2014 was -$77.99K, a 204.38% decline from fiscal 2013.
| Period end | Current Federal Tax Expense (Benefit) 12 month | Current Federal Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | |
| 2015-12-31 | $641.73K 10-K · filed 2016-03-25 | |
| 2014-12-31 | -$77.99K 10-K · filed 2016-03-25 | |
| 2013-12-31 | $74.71K 10-K · filed 2016-03-25 | |
| 2012-12-31 | $89.79K 10-K · filed 2015-03-26 | $0.00 10-K · filed 2013-03-28 |
| 2011-12-31 | -$250.90K 10-K · filed 2014-03-26 | $0.00 10-K · filed 2013-03-28 |
| 2010-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |